Connect your AI

Ionis Pharmaceuticals IONS Debt - Unamortized Discount (Premium) and Issuance Costs, Net

Debt - Unamortized Discount (Premium) and Issuance Costs, Net at other companies

BridgeBio PharmaBBIO

——

Royalty PharmaRPRX

——

ViatrisVTRS

——

AmgenAMGN

——

IQVIAIQV

——

Other financials

Income statement

Revenue$246.1M+87.0%

Gross profit$243.1M+86.8%

Operating income-$117.4M+20.0%

Net income-$92.5M+37.0%

EPS (diluted)-$0.56+39.8%

Balance sheet

Cash & equivalents$173.4M-34.4%

Total debt$691.7M+334%

Total equity$491.4M+3.3%

Total assets$3.4B+22.6%

Cash flow

Operating cash flow-$792.8M-426%

CapEx$21.8M+73.0%

Free cash flow-$814.6M-399%

Valuation

Market cap$12.25B+159%

Enterprise value$12.77B+175%

P/S11.6×+5.0×

Profitability

Gross margin98.4%-0.2pp

Operating margin-33.3%-11.0pp

Net margin-30.9%-10.5pp

FCF margin-77.4%+35.3pp

Returns & leverage

Return on equity-67.6%-20.3pp

Debt / equity1.4×+1.1×

Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DeferredFinanceCostsNet.

The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's debt - unamortized discount (premium) and issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ionis Pharmaceuticals's debt - unamortized discount (premium) and issuance costs, net?: Ionis Pharmaceuticals (IONS) reported debt - unamortized discount (premium) and issuance costs, net of $26.25M in Q4 2025.
What does debt - unamortized discount (premium) and issuance costs, net mean?: Net adjustments to debt value from issuance discounts, premiums, and costs.
How do you interpret debt - unamortized discount (premium) and issuance costs, net?: Changes reflect the amortization schedule of debt-related costs and the impact of market interest rates at the time of issuance.
How does debt - unamortized discount (premium) and issuance costs, net compare across companies?: Standard accounting treatment for debt instruments under GAAP/IFRS.